- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06303700
Dyspnea, Risk of Falling and Quality of Life in Adolescents, Youth and Geriatric Groups
March 4, 2024 updated by: Amira Hussin Hussin Mohammed
To assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics.
Study Overview
Status
Completed
Conditions
Detailed Description
An observational study was done to assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics.
The participants in each group were assessed using the previously mentioned scales.
Then the relationships between them were calculated and analyzed.
Study Type
Observational
Enrollment (Actual)
604
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gamasa, Egypt, 35712
- Amira Hussin Mohammed
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
All subjects were recruited from inhabitants of urban and rural areas in the Nile Delta Region, Egypt.
They were assigned into 3 age-difference groups (adolescents, youth, and geriatrics).
Description
Inclusion Criteria:
The participants were male or female community-dwellers, They ranged in age: adolescents from 12 to 17 years old, youth from 20 to 22 years old, and geriatrics from 60 to 80 years old.
Exclusion Criteria:
subjects with mobility disabilities and severe cognitive impairments.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
adolescents
from both sex, age ranged from twelve to seventeen years old, free from mobility disability and Severe cognitive impairment
|
|
youth
from both sex, age ranged from twenty to twenty-two years old, free from mobility disability and Severe cognitive impairment
|
|
geriatrics
from both sex, age ranged from sixty to eighty years old, free from mobility disability and Severe cognitive impairment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the severity of dyspnea
Time Frame: At the baseline evaluation
|
Using a dyspnea 12 (D-12) questionnaire that assesses the severity of dyspnea using a rubric of the physical and emotional aspects of dyspnea.
|
At the baseline evaluation
|
|
the level of fear of falling through daily life activities
Time Frame: At the baseline evaluation
|
Using Fall efficacy scale (FES-I) questionnaire that assesses the level of fear of falling through daily life activities
|
At the baseline evaluation
|
|
quality of life and public health
Time Frame: At the baseline evaluation
|
Using the Short Form 36 (SF-36) questionnaire.
The questionnaire was assigned to eight domains: physical functioning, role-functioning, bodily pain, general health, vitality, social functioning, and role-emotional and mental health
|
At the baseline evaluation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2022
Primary Completion (Actual)
January 31, 2024
Study Completion (Actual)
January 31, 2024
Study Registration Dates
First Submitted
February 27, 2024
First Submitted That Met QC Criteria
March 4, 2024
First Posted (Actual)
March 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 12, 2024
Last Update Submitted That Met QC Criteria
March 4, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Quality of life
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.